BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $2,198,000 | -23.4% | 25,641 | -41.9% | 4.32% | -35.5% |
Q3 2020 | $2,868,000 | -68.1% | 44,112 | -64.1% | 6.69% | -34.1% |
Q2 2020 | $8,983,000 | -1.5% | 122,865 | -54.1% | 10.16% | +21.9% |
Q1 2020 | $9,116,000 | -37.5% | 267,868 | -0.0% | 8.33% | -28.4% |
Q4 2019 | $14,584,000 | +30.6% | 267,900 | +0.1% | 11.64% | -21.6% |
Q3 2019 | $11,170,000 | – | 267,728 | – | 14.86% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |